| pubmed-article:8772681 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0035173 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0013557 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0190211 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C1273342 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0016011 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C1416485 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:8772681 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
| pubmed-article:8772681 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:8772681 | pubmed:dateCreated | 1996-10-10 | lld:pubmed |
| pubmed-article:8772681 | pubmed:abstractText | In the EPIC trial, c7E3 Fab, an antiplatelet IIb/ IIIa receptor antibody, reduced 30-day ischemic end points after high-risk coronary angioplasty by 35% and 6-month ischemic events by 23% but increased in-hospital bleeding episodes. | lld:pubmed |
| pubmed-article:8772681 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8772681 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8772681 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8772681 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:8772681 | pubmed:issn | 0009-7322 | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:LeeK LKL | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:AndersonK MKM | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:CaliffR MRM | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:BaHH | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:BowmanLL | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:UnterekerW... | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:AversanoTT | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:MaraD DDD | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:TopolE JEJ | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:TalleyJ DJD | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:ClemanM WMW | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:JollisJ GJG | lld:pubmed |
| pubmed-article:8772681 | pubmed:author | pubmed-author:Davidson-RayL... | lld:pubmed |
| pubmed-article:8772681 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8772681 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8772681 | pubmed:volume | 94 | lld:pubmed |
| pubmed-article:8772681 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8772681 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8772681 | pubmed:pagination | 629-35 | lld:pubmed |
| pubmed-article:8772681 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:meshHeading | pubmed-meshheading:8772681-... | lld:pubmed |
| pubmed-article:8772681 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8772681 | pubmed:articleTitle | Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. | lld:pubmed |
| pubmed-article:8772681 | pubmed:affiliation | Economics and Quality of Life Research Group, Duke University Medical Center, Durham, NC 27710, USA. | lld:pubmed |
| pubmed-article:8772681 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8772681 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8772681 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8772681 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8772681 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8772681 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8772681 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8772681 | lld:pubmed |
